Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prostaglandin E1 measurement |
Has measured component |
False |
Alprostadil |
Inferred relationship |
Some |
|
Prostaglandin E1 measurement |
Component |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil |
Is a |
False |
Alprostadil |
Inferred relationship |
Some |
|
Prostaglandin E>1< |
Is a |
False |
Alprostadil |
Inferred relationship |
Some |
|
prostaglandin E>1<-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
dinoproston 10 mg vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
dinoproston 1 mg/ml koncentrat til infusionsvæske, ampul a 0,75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
dinoproston 10 mg/ml koncentrat til infusionsvæske, ampul a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
dinoproston 10 mg/ml koncentrat til infusionsvæske, ampul a 0,5 ml med diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone 400 microgram/mL vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone 3 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing gemeprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Gemeprost 1 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing dinoprostone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing dinoprostone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone 10mg insert |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing alprostadil in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
alprostadil 40,0 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 500 µg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 20,2 µg/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 1000 µg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 500 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 5 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil adverse reaction |
Causative agent |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing alprostadil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
alprostadil 40 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 40 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 20 µg cylinderampul med injektionsvæske, startpakning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 500 µg/ml koncentrat til infusionsvæske, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 10 µg cylinderampul med injektionsvæske, startpakning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 10,16 µg/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 40 µg cylinderampul med injektionsvæske, startpakning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Allergy to alprostadil (finding) |
Causative agent |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 125 µg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 250 µg pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 20micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 10micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil suppositorium a 500 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil suppositorium a 250 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil suppositorium a 125 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil suppositorium a 1000 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 5mcg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 20 µg cylinderampul med injektionsvæske i sprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 10 µg cylinderampul med injektionsvæske i sprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing alprostadil in genitourinary dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Allergy to alprostadil (finding) |
Causative agent |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 40micrograms powder for conventional release solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 125 microgram urethral stick |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 250 microgram urethral stick |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil-containing product in urethral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 40 microgram powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 40 microgram powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 5 microgram powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 5 microgram powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing only alprostadil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing only alprostadil in urethral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 250 microgram urethral stick |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 250 microgram urethral stick |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 125 microgram urethral stick |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 125 microgram urethral stick |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 500 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 500 microgram/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 500 microgram/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |